Juvenile Idiopathic Arthritis
Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.
Teenagers with juvenile idiopathic arthritis and their parents enjoyed participating in an internet-based intervention designed to improve accessibility and disease self-management.
Patients with juvenile idiopathic arthritis receiving biologic therapy have high rates of serious infections.
Technological advances can be helpful in juvenile idiopathic arthritis and are particularly well suited to younger people in general, who are more comfortable with device technologies and more likely to adopt them.
In patients with juvenile idiopathic arthritis, levels of serum vitamin D are closely related to cholesterol levels and other risk factors for cardiovascular disease.
Children with juvenile idiopathic arthritis using anti-TNFIs have a significantly higher risk for infection compared with children using DMARDs.
Clinical Pain Advisor Articles
- Cannabis Use High in Migraine
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Percutaneous Electrolysis May Be Useful Adjunct for Subacromial Pain Syndrome
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Targeted Educational Intervention Helped Reduce Opioid Exposure in Adult Inpatients
- Systematic Cross-Checking May Reduce Medical Errors in Emergency Departments
- Corticosteroid Plus Lidocaine Injections Do Not Alleviate Pain in Central Lumbar Spinal Stenosis
- Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis